NEW YORK, March 19, 2019 /PRNewswire/ -- Oppenheimer &
Co. Inc. ("Oppenheimer"), a unit of Oppenheimer Holdings (NYSE:
OPY), will host its 29th Annual Healthcare Conference in
New York City on March 19 and 20, 2019. The two-day conference
will bring together leading public and private companies across
major sectors of the healthcare industry, including Allogene,
Caribou, Centene, Cigna, Exelixis, GlaxoSmithKline, HCA, Humana,
KSQ Therapeutics, Madrigal, Moderna, Pear Therapeutics, Tandem
Diabetes and United Therapeutics. The Marwood Group will
present the keynote lunch address on Tuesday, while Wednesday's
keynote lunch speaker will be Dr. Jason
Luke from the University of
Chicago, who will address how to spot red flags in early
clinical trials.
Through panel and company presentations, group meetings and
1on1's, the event will provide investors with cutting-edge insights
on developing trends within the healthcare industry, including
Medicare and Medicaid policy changes, blockbuster pharmaceutical
and biotechnology products, and evolving payment models. The
conference will also feature seven panels discussing critical
topics in the life science, medical technology, and healthcare IT
sectors, including immunotherapy treatment for cancer, next steps
in diabetes research, bispecifics, and the endocannabinoid
system.
Michael Margolis, R.Ph., co-head
of Healthcare Investment Banking, and Stefan Loren, Ph.D., Managing Director, will
also lead a panel titled Getting Public in Challenging Market
Environments – looking at IPOs versus Alternative Public
Offerings (APOs). This panel is sponsored by Mintz, Levin, Cohn,
Glovsky & Popeo and ZAG-S&W.
The conference will feature Oppenheimer's Senior Research
Analysts including the following:
- Matthew Biegler, Senior Analyst
covering Emerging Biotechnology
- Mark Breidenbach, Ph.D.,
Executive Director and Senior Analyst covering Biotechnology
- Kevin DeGeeter, Managing
Director and Senior Analyst covering Biotechnology and
Diagnostics
- Leland Gershell, Managing
Director and Senior Analyst covering Biopharmaceuticals
- Steven Lichtman, Managing
Director and Senior Analyst covering Medical Devices
- Mohan Naidu, Managing Director
and Senior Analyst covering the Healthcare Information
Technology (HCIT) sector
- Jay Olson, Executive Director
and Senior Analyst covering Biotechnology
- Esther Rajavelu, Executive
Director and Senior Analyst covering Biotech & Specialty
Pharmaceuticals
- Hartaj Singh, Managing Director and Senior
Analyst covering Biotechnology
- Silvan Tuerkcan Ph.D., Senior Analyst covering
Biotechnology
- Michael Wiederhorn, Managing
Director and Senior Analyst covering Healthcare Providers and
Services
"The healthcare ecosystem is vast and multifaceted," said
Erica L. Moffett, Managing Director
and Head of Research Marketing Services. "With changing policies,
innovative platforms, and new advancements in technology
revolutionizing the healthcare and pharmaceutical business, our
clients, now more than ever, rely on our expertise to help them
better understand the industry. The conference will promote
learning and education so investors leave with key insights to help
their portfolios."
Oppenheimer's next healthcare conference will be the
Biotech Summit by the Lake
featuring Northwestern University's
Chemistry of Life Processes Institute on March 29 in Evanston,
Illinois. Upcoming conferences also include Oppenheimer's
Oncology Insights Summit in New
York on May 16, a MedTech
Summit on May 29 in San Francisco, and Summit for Emerging
Biotechnology in Montauk, New York
on June 27 and 28.
Oppenheimer & Co. Inc.
Oppenheimer & Co. Inc.
(Oppenheimer), a principal subsidiary of Oppenheimer Holdings Inc.
(OPY on the New York Stock Exchange), and its affiliates provide a
full range of wealth management, securities brokerage and
investment banking services to high-net-worth individuals,
families, corporate executives, local governments, businesses and
institutions.
View original
content:http://www.prnewswire.com/news-releases/from-new-treatments-to-changing-policies-industry-leaders-discuss-changing-healthcare-landscape-at-oppenheimer--co-incs-annual-conference-300814595.html
SOURCE Oppenheimer & Co. Inc.